BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12408102)

  • 1. Editorial comment: a tale of two viruses.
    Dieterich DT
    AIDS Read; 2002 Oct; 12(10):448-9. PubMed ID: 12408102
    [No Abstract]   [Full Text] [Related]  

  • 2. Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus.
    Benhamou Y; Tubiana R; Thibault V
    N Engl J Med; 2003 Jan; 348(2):177-8. PubMed ID: 12519935
    [No Abstract]   [Full Text] [Related]  

  • 3. Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication.
    van Bömmel F; Wünsche T; Schürmann D; Berg T
    Hepatology; 2002 Aug; 36(2):507-8. PubMed ID: 12143063
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'.
    Matthews GV; Dore GJ
    AIDS; 2007 Mar; 21(6):777-8. PubMed ID: 17413705
    [No Abstract]   [Full Text] [Related]  

  • 5. Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation.
    Van Bömmel F; Schernick A; Hopf U; Berg T
    Gastroenterology; 2003 Feb; 124(2):586-7. PubMed ID: 12557178
    [No Abstract]   [Full Text] [Related]  

  • 6. High rate of virologic failure with once-daily ddI/3TC/TDF.
    IAPAC Mon; 2003 Nov; 9(11):279. PubMed ID: 14989185
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
    Quiros-Roldan E; Calabresi A; Lapadula G; Tirelli V; Costarelli S; Cologni G; Zaltron S; Puoti M; Carosi G; Torti C
    Antivir Ther; 2008; 13(3):341-8. PubMed ID: 18572746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [First nucleotide analog against HIV. Lowers viral load also in drug resistance].
    MMW Fortschr Med; 2002 Aug; 144(33-34):60-1. PubMed ID: 12380157
    [No Abstract]   [Full Text] [Related]  

  • 9. Tenofovir helps beat hepatitis B.
    TreatmentUpdate; 2003 Jan; 15(1):4. PubMed ID: 12630369
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tenofovir in Study 903. Also effective and tolerable in first-line therapy].
    MMW Fortschr Med; 2002 Aug; 144(33-34):61. PubMed ID: 12380158
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial comment: HIV and HBV coinfection--a coming-of-age in treatment strategies.
    Ala A; Dieterich DT
    AIDS Read; 2004 Mar; 14(3):134-5. PubMed ID: 15068001
    [No Abstract]   [Full Text] [Related]  

  • 12. Ninety-six-week efficacy of combination therapy with lamivudine and tenofovir in patients coinfected with HIV-1 and wild-type hepatitis B virus.
    Bani-Sadr F; Palmer P; Scieux C; Molina JM
    Clin Infect Dis; 2004 Oct; 39(7):1062-4. PubMed ID: 15472862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenofovir drug interactions: ddI and d4T.
    TreatmentUpdate; 2003; 15(2):7. PubMed ID: 12693363
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis B infection in an HIV-positive man treated with tenofovir: a case of re-infection or reactivation?
    Richardson D; Lamba H
    Int J STD AIDS; 2004 Mar; 15(3):204-5. PubMed ID: 15038871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promising results for tenofovir.
    AIDS Patient Care STDS; 2000 Jul; 14(7):396. PubMed ID: 10935058
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection.
    Schmutz G; Nelson M; Lutz T; Sheldon J; Bruno R; von Boemmel F; Hoffmann C; Rockstroh J; Stoehr A; Wolf E; Soriano V; Berger F; Berg T; Carlebach A; Schwarze-Zander C; Schürmann D; Jaeger H; Mauss S
    AIDS; 2006 Oct; 20(15):1951-4. PubMed ID: 16988516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More uses for tenofovir?
    AIDS Treat News; 2001 Jan; (377):4. PubMed ID: 11862808
    [No Abstract]   [Full Text] [Related]  

  • 18. Tenofovir DF and emtricitabine vs. zidovudine and lamivudine.
    Jenny-Avital ER
    N Engl J Med; 2006 Jun; 354(23):2506-8; author reply 2506-8. PubMed ID: 16764056
    [No Abstract]   [Full Text] [Related]  

  • 19. The potential place of tenofovir in antiretroviral treatment regimens.
    Gazzard BG
    Int J Clin Pract; 2001 Dec; 55(10):704-9. PubMed ID: 11777298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gilead sciences releases Viread.
    Giles C
    Surviv News (Atlanta Ga); 2002 Jan; ():15. PubMed ID: 11870987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.